Oruka Therapeutics (ORKA) has strong technical momentum and is trading at a new 5-year high. Shares are up nearly 840% over the past year. ORKA maintains a 100% “Buy” technical opinion from Barchart. However, Oruka is highly speculative and has elevated short interest. Today’s Featured Stock Valued at $2.79 billion, Oruka Therapeutics (ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. What I’m Watching I found today’s Chart of the Da ...